Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Change in Account Payables (2015 - 2026)

Cellectis (CLLS) posted quarterly Change in Account Payables of -$3.9 million for Q1 2026, up 38.65% year-over-year from -$2.8 million in Q1 2025, and down 856.47% quarter-over-quarter from $510000.0 in Q3 2025.

Analysis

Cellectis (CLLS) Change in Account Payables (2015 - 2026) Analysis & Trends

Cellectis' Change in Account Payables history runs 12 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 38.65% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$9.6 million (down 682.31% YoY), while the FY2024 annual figure was $2.1 million, up 132.59% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$3.9 million, down from $510000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $7.3 million in Q2 2022, with the low at -$6.5 million in Q1 2022.
  • The 5-year median for Change in Account Payables is -$106000.0 (2024), against an average of -$663562.5.
  • The sharpest annual moves came in 2023 and 2024: Change in Account Payables plunged 200.34% in 2023, then soared 524.47% in 2024.
  • Cellectis' Change in Account Payables stood at $1.8 million in 2022, then slumped by 200.34% to -$1.8 million in 2023, then jumped by 268.13% to $3.0 million in 2024, then tumbled by 82.74% to $510000.0 in 2025, then tumbled by 856.47% to -$3.9 million in 2026.
  • Business Quant data shows CLLS's Change in Account Payables at -$3.9 million in Q1 2026, $510000.0 in Q3 2025, and $23000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cellectis 321.90 Mn 155.05 Mn - 3.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.84 Mn
Mar 31, 2026 -3.86 Mn
Dec 31, 2025 2.50 Mn
Sep 30, 2025 510,000.00
Jun 30, 2025 23,000.00
Mar 31, 2025 -6.29 Mn
Dec 31, 2024 2.95 Mn
Sep 30, 2024 -235,000.00
Jun 30, 2024 5.22 Mn
Mar 31, 2024 -5.89 Mn
Dec 31, 2023 -1.76 Mn
Sep 30, 2023 2.89 Mn
Jun 30, 2023 -1.23 Mn
Mar 31, 2023 -6.21 Mn
Dec 31, 2022 1.75 Mn
Sep 30, 2022 700,000.00
Jun 30, 2022 7.27 Mn
Mar 31, 2022 -6.47 Mn
Dec 31, 2021 2.35 Mn
Sep 30, 2021 -4.50 Mn